Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Elnusa Tbk. (ELSA) vs Tempo Scan Pacific Tbk. (TSPC)

Elnusa Tbk.Trading
Tempo Scan Pacific Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Elnusa Tbk. dan Tempo Scan Pacific Tbk.: Elnusa Tbk. diperdagangkan di Rp650 (kapitalisasi pasar 4,82 T, volume 24 jam 17,35 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.520 (kapitalisasi pasar 11,18 T, volume 24 jam 613 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 2,3× kapitalisasi pasar Elnusa Tbk., dan Elnusa Tbk. lebih aktif diperdagangkan (17,35 jt vs 613 rb). Mana yang lebih baik tergantung tujuan investasimu.

ELSATSPC
Kapitalisasi Pasar
4,82 T11,18 T
Volume
17,35 jt613 rb
Lot
173,5 rb6,13 rb
Perputaran
11,24 M1,54 M
Harga Rata-rata
648,032.511,52
Nilai Transaksi
11,24 M1,54 M
Harga Ekuilibrium Indikatif
6502.520
Volume Ekuilibrium Indikatif
7,68 rb17

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

ELSA
Lihat detail
TSPC
Lihat detail

Tentang Elnusa Tbk.

PT Elnusa Tbk (Company) was established under the name of PT Elektronika Nusantara on January 25, 1969 based on notarial deed No.18 of Tan Thong Kie, S.H., dated January 25, 1969, as amended by notarial deed No. 10 of the same notary dated February 13, 1969. The Company’s articles of association has been amended several times, most recently by notarial deed No. 2 of Soegeng Santosa, S.H., dated Jan 7, 2002, concerning among others, the change in the Company’s name and public offering.

Selengkapnya di halaman ELSA

Tentang Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Selengkapnya di halaman TSPC